Paltimatrectinib - CAS 2353522-15-1

Paltimatrectinib (PBI-200) is a potent tyrosine kinase inhibitor with anticancer activity that inhibits myosin-related kinase A (TrkA) .Paltimatrectinib is used in the study of bladder, breast and colorectal cancers.

Tyrosine Kinases, Trk receptor, Tyrosinase

Tyrosine Kinase/Adaptors, Proteases/Proteasome

2353506

0.9996

C20H15F5N6

434.37

[H][C@@]1(CCCN1c1ccn2ncc(-n3cc(cn3)C(F)(F)F)c2n1)c1cc(F)ccc1F

-20°C

Ice Packs

Small Compound